Trading Day Triumph: Qiagen NV (QGEN) Ends at 43.77, a -5.73 Surge/Plunge

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

Qiagen NV (NYSE: QGEN) closed the day trading at $43.77 down -5.73% from the previous closing price of $46.43. In other words, the price has decreased by -$5.73 from its previous closing price. On the day, 1.04 million shares were traded. QGEN stock price reached its highest trading level at $44.84 during the session, while it also had its lowest trading level at $43.545.

Ratios:

For a better understanding of QGEN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.62 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.14. For the most recent quarter (mrq), Quick Ratio is recorded 1.89 and its Current Ratio is at 2.17. In the meantime, Its Debt-to-Equity ratio is 0.54 whereas as Long-Term Debt/Eq ratio is at 0.39.

On December 10, 2024, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $42.50 to $54.

HSBC Securities Downgraded its Buy to Hold on October 17, 2024, while the target price for the stock was maintained at $49.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 11 ’24 when Sackers Roland bought 25,000 shares for $46.00 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QGEN now has a Market Capitalization of 9457953792 and an Enterprise Value of 10851897344. As of this moment, Qiagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 105.42, and their Forward P/E ratio for the next fiscal year is 18.67. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 17.37. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.98 while its Price-to-Book (P/B) ratio in mrq is 2.68. Its current Enterprise Value per Revenue stands at 5.519 whereas that against EBITDA is 16.208.

Stock Price History:

The Beta on a monthly basis for QGEN is 0.36, which has changed by -0.00815773 over the last 52 weeks, in comparison to a change of 0.23095727 over the same period for the S&P500. Over the past 52 weeks, QGEN has reached a high of $49.30, while it has fallen to a 52-week low of $40.15. The 50-Day Moving Average of the stock is -4.23%, while the 200-Day Moving Average is calculated to be -2.76%.

Shares Statistics:

Over the past 3-months, QGEN traded about 937.32K shares per day on average, while over the past 10 days, QGEN traded about 1512190 shares per day. A total of 221.85M shares are outstanding, with a floating share count of 221.23M. Insiders hold about 0.28% of the company’s shares, while institutions hold 78.64% stake in the company. Shares short for QGEN as of 1736899200 were 2958468 with a Short Ratio of 3.25, compared to 1734048000 on 3625089. Therefore, it implies a Short% of Shares Outstanding of 2958468 and a Short% of Float of 1.79.

Dividends & Splits

The current Payout Ratio is 0.00% for QGEN, which recently paid a dividend on 2024-01-30 with an ex-dividend date of 1738108800. Stock splits for the company last occurred on 2017-01-25 when the company split stock in a 962:1000 ratio.

Earnings Estimates

Its stock is currently analyzed by 11.0 different market analysts. The consensus estimate for the next quarter is $0.5, with high estimates of $0.52 and low estimates of $0.47.

Analysts are recommending an EPS of between $2.28 and $2.17 for the fiscal current year, implying an average EPS of $2.24. EPS for the following year is $2.35, with 16.0 analysts recommending between $2.57 and $2.25.

Revenue Estimates

11 analysts predict $518.54M in revenue for the current quarter. It ranges from a high estimate of $522.34M to a low estimate of $502M. As of the current estimate, Qiagen NV’s year-ago sales were $509.16MFor the next quarter, 11 analysts are estimating revenue of $477.49M. There is a high estimate of $486M for the next quarter, whereas the lowest estimate is $465.88M.

A total of 20 analysts have provided revenue estimates for QGEN’s current fiscal year. The highest revenue estimate was $1.99B, while the lowest revenue estimate was $1.97B, resulting in an average revenue estimate of $1.98B. In the same quarter a year ago, actual revenue was $1.97BBased on 20 analysts’ estimates, the company’s revenue will be $2.08B in the next fiscal year. The high estimate is $2.18B and the low estimate is $2.03B.

Most Popular